MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
SLN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Silence Therapeutics (SLN) Ownership - Who owns Silence Therapeutics?

Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
12 Hammersmith Grove
Phone
+44 2034576900
Employees
88
Web
https://www.silence-therapeutics.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
150.21M
P/E Ratio
N/A
Total Cash
70.08M
Projected Growth
N/A
Total Debt
136K
Revenue
839K
Risk (Beta)
2.65
Dividend Yield
N/A
Total Cash/Share
1.48
Total Debt/Equity
N/A
Revenue/Share
0.02 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
SLN
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for SLN
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
12 Hammersmith Grove
Phone
+44 2034576900
Employees
88
Web
https://www.silence-therapeutics.com